Salary and grade: Grade 7 £45,568 up to £50,764 (pay award pending 1 April 2024)
Contact Type: Permanent
Hours: Full time, 37 hours per week
Location: The designated office base is Abbey House, Abingdon, Flexible/hybrid
REF-211 739
Abou...
About the Company Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transformative medicines which address unmet patient needs in oncol...
Adaptimmune is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immunotherapy products for people with cancer. The Company's unique SPEAR (Specific Peptide Enhanced Affinity Receptor) T-cell platfo...
About the Company Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transformative medicines which address unmet patient needs in oncol...
Principal Responsibilities
~ Ensuring all Maintenance / Reactive proposals are produced and provided to the customer in accordance with agreed KPIs or 5 working days whichever is the shorter. Note that any life safety critical repair should be...
Electrical Maintenance Engineer page is loaded Electrical Maintenance Engineer
Apply locations Abingdon time type Full time posted on Posted 7 Days Ago job requisition id JOB ID-08861 We are currently recruiting for an experienced Electrical Ma...
Are you a skilled Process Engineer , looking to join an expanding business based in Abingdon? If you are looking for a new opportunity to be part of a forward-thinking company with excellent career prospects, we would love to hear from you!
We...
Evotec, Aptuit’ s parent company, is a leader in the discovery and development of novel therapeutics of all modalities with operational sites in the UK, Europe (Germany, Italy and France) as well as the US. Aptuit Oxford provides integrated Chemistr...
Adaptimmune is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immunotherapy products for people with cancer. The Company's unique SPEAR (Specific Peptide Enhanced Affinity Receptor) T-cell platfo...
